Friday, January 24, 2025
Sunnybrook Research Institute has licensed advanced focused ultrasound technology for neuromodulation to Grey Matter Neurosciences. The technology holds transformative potential in the treatment of Alzheimer’s and other brain diseases and disorders.
Tuesday, November 12, 2024
Dr. Juan Carlos Zúñiga-Pflücker, senior scientist in the Odette Cancer Research Program and co-founder of SRI spin-off company Notch Therapeutics, is developing innovative therapies from asking fundamental questions.
Thursday, October 17, 2024
The combined company will focus on continuing to commercialize and develop Conavi’s Novasight Hybrid™ System designed to guide common minimally invasive coronary procedures.
Monday, October 7, 2024
Arrayus Technologies Inc., a SRI spin-off company, is pleased to announce that its MRI-guided FUS system has been granted approval by Health Canada for the ablation of uterine fibroid tissue.
Monday, September 9, 2024
Dr. Hon Leong emphasizes the importance of translating research into clinical practice. Using ideas from his lab, Dr. Leong’s company, Yex, is advancing research in regenerative medicine, antibody production, clinical diagnostics, and drug discovery.
